TPM.SG - Tonix Pharmaceuticals Holding Corp

Stuttgart - Stuttgart Delayed price. Currency in EUR
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
79,498
81,876
68,838
36,157
18,192
Selling general and administrative
29,344
30,215
23,474
14,354
10,636
Total operating expenses
108,842
112,091
92,312
50,511
28,828
Operating income or loss
-108,842
-112,091
-92,312
-50,511
-28,828
Income before tax
-108,091
-110,218
-92,287
-50,463
-28,618
Income from continuing operations
-108,091
-110,218
-92,287
-50,463
-28,618
Net income
-108,091
-110,218
-92,287
-50,463
-28,618
Net income available to common shareholders
-112,346
-116,877
-92,287
-52,174
-31,092
Basic EPS
-
-20.44
-50.62
-110.00
-3.87k
Diluted EPS
-
-20.44
-50.62
-110.00
-3.87k
Basic average shares
-
5,718
1,822
472.958
8.042
Diluted average shares
-
5,718
1,822
472.958
8.042
EBITDA
-
-112,091
-92,312
-50,511
-28,828